Skip to content
Screener

Phreesia PHR Cash & Equivalents

Discontinued — last reported Q4 '26

Cash & Equivalents at other companies

Veeva Systems logo
Veeva SystemsVEEV
$1.9B-3.5%
OptimizeRx logo
OptimizeRxOPRX
$20.17M+21.7%
Claritev Corporation logo
Claritev CorporationCTEV
$27.68M-58.9%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$2.11M+39.8%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$888.8M+1,598%
ExlService Holdings logo
ExlService HoldingsEXLS
$146.77M-13.9%

Other financials

Income statement

See full
Revenue$130.9M+12.9%
Gross profit$113.3M+14.1%
Operating income$6.7M+305%
Net income$3.0M+176%
EPS (diluted)$0.05+171%

Balance sheet

See full
Total debt$98.3M+242%
Total equity$359.1M+27.3%
Total assets$666.1M+66.4%

Cash flow

See full
Operating cash flow$23.9M+61.1%
CapEx$4.3M+23.0%
Free cash flow$19.6M+72.9%

Valuation

See full
Market cap$773.27M-52.1%
P/E84.2×
P/S1.6×-2.0×

Profitability

See full
Gross margin85.4%+0.8pp
Operating margin0.7%+0.4pp
Net margin1.9%+1.0pp
FCF margin15.3%+6.9pp

Returns & leverage

See full
Return on equity2.9%+1.5pp
Debt / equity0.3×+0.2×
Current ratio1.8×-0.2×

Where this comes from

Reported directly by Phreesia in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The source filing: Phreesia’s 10-K, filed March 31, 2026.

Filed
Mar 31, 2026, 4:02 PM EDT
Fiscal year
FY2026
Accession
0001412408-26-000079
Line itemJanuary 31, 2026January 31, 2025
Assets
Current:
Cash, cash equivalents, and restricted cash (including restricted cash of $1,691)$73,830$84,220
Settlement assets32,99929,176
Accounts receivable, net of allowance for doubtful accounts of $1,523 and $1,468 as of January 31, 2026 and 2025, respectively97,45373,617
Cardholder receivables38,330
Deferred purchase price receivables18,003
Accrued interest and fees receivables840

Item 8. Financial Statements and Supplementary Data

FAQ

What is Phreesia's cash & equivalents?
Phreesia (PHR) reported cash & equivalents of $73.83M in Q4 2025.
How has Phreesia's cash & equivalents changed year-over-year?
Phreesia's cash & equivalents decreased by 12.3% year-over-year, from $84.22M to $73.83M.
What is the long-term trend for Phreesia's cash & equivalents?
Over 5 years (2021 to 2026), Phreesia's cash & equivalents has grown at a -19.5% compound annual growth rate (CAGR), from $218.78M to $73.83M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Phreesia's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude